The impact of apo E polymorphism on interindividual variation in plasma lipid, lipoprotein concentrations, and LDL subfraction profiles was studied in 201 well-defined patients (88 men and 103 women) with familial combined hyperlipidemia (FCH). When corrected for the concomitant influences of age, gender and obesity, the allelic variation in the apo E gene was shown to explain a statistically significant portion of the variability in lipid and (apo)lipoprotein concentrations. Carriers of the apo e2 allele exhibited a substantially higher plasma triglyceride concentration and a lower low density lipoprotein (LDL) cholesterol level, while subjects with the apo eA allele had significant higher total plasma cholesterol and LDL cholesterol levels. In line with this observation, our FCH population was characterized by an over-representation of the apo E4 allele as compared with a Dutch standard population (x 2 = 55.2, P < 0.0001). The contribution of apo E polymorphism to trait variability was different between sexes for plasma triglyceride, VLDL cholesterol, VLDL triglycerides, and high density lipoprotein (HDL) cholesterol levels. Apo E polymorphism had no impact on chemical composition of VLDL; for LDL particles the apo el allele was associated with a lower cholesterol to protein (C/P) ratio, whereas the opposite was true for the apo s4 allele. Despite the demonstrated impact of apo E polymorphism on plasma lipids and LDL chemical composition, in all phenotypic groups a dense LDL subfraction profile predominated. Thus, apo E polymorphism contributes to the lipid phenotypic expression in FCH, whereas further evidence was obtained that a dense LDL subfraction profile is an integral feature of FCH. P II S0021 -9150(96)05924-2 314 S.J. H. BreiJie et al. / Atherosclerosis 126 (1996) [313][314][315][316][317][318][319][320][321][322][323][324] 
Introduction of a common defect assumed by its inherited
Familial combined hyperlipidemia (FCH) is a common heritable lipid disorder, in which affected individuals show elevations of plasma cholesterol, total triglycerides or both, with lipid phenotypes occurring within affected first-degree relatives, together with a high prevalence of pre mature cardiovascular disease [1] [2] [3] . Originally, it was supposed that FCH was caused by the vari able expression of a single autosomal dominant gene with primary action on plasma triglyceride levels and secondary on cholesterol levels [1] . Nowadays, FCH is considered to be more hetero geneous, with on the one hand hepatic VLDL overproduction [4, 5] , possibly amplified by addi tional defects as insulin resistance, and on the other hand a deficiency in the clearance of circu lating triglyceride-rich lipoproteins [6] , To the lat ter molecular defects in the LpL gene may contribute [7] .
Apolipoprotein (apo) E, consisting of 3 com mon isoforms E2, E3 and E4, is one of the major protein constituents of chylomicrons and VLDL remnants, and is involved in the subsequent catabolism of these particles by allowing specific binding to hepatic receptors. Population studies have shown that the apo E polymorphism could explain a significant part of the inter-individual variability in plasma cholesterol and LDL choles terol [8 -10] . In these studies, the apo ¿'2 allele was frequently associated with lower levels of total plasma cholesterol, LDL cholesterol and apo B, whereas for the apo ¿4 allele the opposite was observed, inherent to the different binding activi ties of apo E isoproteins to the hepatic receptor [11] [12] [13] . Similar effects on lipid and lipoprotein concentrations due to apo E polymorphism were documented in a homogeneous sample of pi with familial same LDL receptor mutation [14] . These effects i the to be of age, and body mass index (BMI), similar to reported epi demiological observations [15, 16] . Consequently, the effects of apo E polymorphism, age, gender and BMI may, at least in part, also explain the great interindividual variability in lipid pheno typic expression in FCH, despite the probability nature.
Therefore, the objective of this study was to estimate the specific impact of apo E polymor phism on plasma lipids, lipoproteins and LDL subfraction profiles in well-defined FCH patients, taking concomitant influences of age, gender and BMI into account.
Subjects and methods

Families
As a part of an ongoing study aiming at the identification of biochemical and genetical aspects underlying FCH, extended FCH kindreds were recruited by family studies of probands attending the out-patient clinic of the Academic Hospital of Nijmegen. These probands repeatedly exhibited a combined hyperlipidemia with both plasma cholesterol and triglyceride concentrations above the 90th percentile for age and gender. Families were only included when they satisfied the follow ing criteria: the presence of a multiple type hyper lipidemia in first-degree relatives with elevated levels of total plasma cholesterol and/or triglyce rides using the age-and sex-related 90th percentile upper levels of the prospective cardiovascular Münster (PROCAM ) study [17] . Thus, besides a proband presenting a combined the presence of at least one first-degree relative with hypertriglyceridemia or hypercholesterolemia was obligatory. Furthermore, at least one of the first-degree relatives should have cardiovascular disease before the age of 60 years.
Families were excluded when first-degree family members had xanthomata. All i L i a Is were Caucasian with an age of 12 years or older. Information on medical status (i.e., diabetes, renal impairment and liver alcohol intake, smoking habits, and hormonal status in women was collected by questionnaire. The study protocol was approved by the ethical committee of our Institute. None of the probands was homozygous for the apo i:2 allele or had hyperlipidemia due to a secondary cause (i.e., diabetes mellitus, hypothyroidism and hepatic or renal impairment), which was excluded by stan dard laboratory tests. Hypolipidemic drugs were discontinued at least 4 weeks prior to drawing of the blood.
Plasma
position of each VLDL or LDL particle is expressed in percentage of dry mass of each con tributing component (i.e., free cholesterol, choles terol esters, triglycerides, phospholipids and proteins). Total plasma apo B concentrations were determined bv immunonenh el om etrv 1701.
Overnight fasted venous blood samples were drawn by vein puncture into K3EDTA containing vacutainer tubes. Non-local participants were vis ited at their homes, and blood was transported directly to the laboratory. On arrival at the labo ratory within 2 h, plasma was isolated for deter mination of the lipid and lipoprotein levels, and the LDL subfraction profile.
Plasma lipid and lipoprotein assays and apo E phenotype determination
VLDL was isolated from whole plasma by ul tracentrifugation at density 1.006 g/ml for 16 h at 36,000 rpm in a fixed angle rotor (TFT 45.6 rotor, Kontron, Zürich), in a Beckman L7-55 ultracen trifuge (Beckman, Palo Alto, CA). High density lipoprotein (HDL) cholesterol was determined by the polyethylene glycol 6000 method [18] . LDL cholesterol was calculated by subtraction of VLDL cholesterol and HDL cholesterol from to tal plasma cholesterol. For determination of its chemical composition LDL was isolated by se quential ultracentrifugation of the VLDL infranatant for another 20 h. Total cholesterol and triglyceride concentrations were determined by enzymatic, commercially available reagents M FRG, cat. no. 237574 Miles tively). To obtain the chemical composition data of VLDL and LDL additional unesterified choles terol and phospholipids were determined using commercially available reagents (Boehringer-Mannheim, FRG, cat. no. 310328, 691844). The protein content of VLDL and LDL was deter mined using the Lowry method [19] with chloro form extraction to remove turbidity due to lipids. From these data the mean ratio of cholesterol To achieve accurate results in relation to the Center for Disease Control Standardisation Pro gram, the obtained values were recalculated on the basis of an exchange of sera with Dr. S Marco vina (Northwest Lipid Research Labora tory, Seattle, WA). Apo E phenotypes were deter mined after iso-electric focusing of VLDL lipoproteins, as described previously [21] . Results obtained for 534 samples agreed, with two excep tions, well in comparison to apo E genotyping according to Hixson et al. [22] (performed by Dr. M.J.V. Hoffer, MGC-Department of Human Ge netics, Leiden University, Leiden).
LDL sub fractionation
LDL subfractions were detected by single spin density gradient ultracentrifugation [23] . After ul tracentrifugation up to five LDL subfractions could be distinguished as distinct bands in the middle of the tube concentrated in the following density ranges: LDL1 (1.030-1.033g/ml), LDL2 (1.033-1.040 g/ml), LDL3 (1.040-1.045 g/ml), LDL4 (1.045-1.049 g/ml), and LDL5 (1.049-1.054 g/ml). The ultracentrifugation tubes, con taining the LDL subfractions stained with Coomassie Brilliant Blue R, were placed in a specially designed rack and photographed. Accu rate documentation of the different LDL subfrac tion patterns was obtained by scanning the obtained slides in triplicate on a LKB 2202 ultra scan laser densitometer (Pharmacia, Uppsala, Sweden). The mean peak heights (hl-h.5) of the LDL subfractions (LDL1-LDL5) on the three scans were used to calculate the variable K as a continuous variable, that best describes each indi vidual LDL subfraction pattern [24] . The contri bution of each LDL subfraction, expressed by its peak height (%hl-%h5) relative to the total LDL (unesterified cholesterol plus cholesterol moiety of subfraction profile, (total LDL [100%] -%hl + cholesterol ester [ » 0.59*weight of cholesterol es-%h2 + %h3 + %h4 + %h5), was calculated. The ter]) to protein was calculated. The chemical com-relative peak heights of LDL3 and the less fre- Table 1 were evaluated by Student's t test. Allele frequencies were determined by the genecounting method under the hypothesis of a Hardy-Weinberg equilibrium. Differences in apo E phenotype frequencies between FCH relatives and either spouses or a representative sample of the Dutch population [8] were evaluated by the X 2 test. Multiple regression analysis was used on the parameters to estimate the possible concomi tant effects of age, gender, BMI, smoking habits, and hormonal status in women. Initially, af fected FCH subjects were distinguished from un affected relatives on the basis of elevated lipid concentrations (total plasma cholesterol ^6.5 mmol/1 and/or plasma triglycerides S:2.0 mmol/ 1). By this classification age, gender and BMI significantly contributed to the variation of a majority of the parameters, whereas smoking habits and hormonal status in women did not. When percentile data (total plasma cholesterol and/or total plasma triglycerides > 90th percen tile for age and gender) were used to identify affected relatives, age and BMI did not con tribute anymore to the variation in the parame ters, since these concomitant effects appeared to be incorporated in the percentile data itself. Therefore, the actually presented analyses were performed with data o f relatives classified by us ing the percentile data. A two-way ANOVA with independent variables 'apo E phenotype' and 'sex' towards dependent lipid parameters followed by Scheffe's post-hoc multiple compari son test was performed to determine the effects of apo E polymorphism on plasma lipids, (apo)lipoproteins, the chemical composition of VLDL and LDL and the LDL subfraction profile, for each sex separately. Statistical analy ses were performed by the Department of Medi cal Statistics using procedures available in the Statistical Analysis System software package (SAS Institute, Cary, N.C.). A trait difference with P < 0.05 was considered to be significant. 
Statistical methods
All statistical analyses were performed for af fected FCH relatives as a group and because of different frequency distributions in men and women for plasma lipids, lipoproteins, and con comitant effects (i.e. age and BMI), shown by epidemiological studies [15,25], also an addi tional analysis was performed for men and women separately. Differences between men and women for the quantitative trait means depicted in
Results
Subjects
In total, 40 multi-generational FCH kindreds including 660 individuals (558 FCH relatives and 102 spouses) were used in this study. Based on percentile data, 201 individuals were found to be affected by exhibiting a total plasma cholesterol and/or a plasma triglyceride concentration above the 90th percentile for age and gender. The an thropometric measurements of the affected sub jects, as well as the plasma lipid and lipoprotein levels (88 men and 113 women) are shown in Table 1 
. Both in men as well as in women mean age and BMI were similar. Men exhibited higher concentrations of plasma triglycerides, VLDL cholesterol, VLDL triglycerides and apo B, and lower concentrations of HDL cholesterol. Total plasma cholesterol and LDL cholesterol concen trations were not different between sexes. Despite lower triglyceride levels in women, both sexes had, on the average, a substantial negative K value, which represents a LDL subfraction profile
in which small dense LDL particles predominate. This feature was more pronounced in men. Table 2 
Phenotype and allele frequencies
depicts the phenotype and allele fre quencies in our sample of Dutch FCH patients and unaffected relatives compared to a standard Dutch control population [8]. Apo E phenotype and apo i: allele frequencies in spouses (n 102)
were similar compared to the Dutch control pop ulation, but differed significantly from those in and unaffected FCH relatives ( Table 2) . frequency was comparable in and controls, but the apo rA relatives, especially in
The apo e.2 both FCH rek frequency in FCH patients, was higher.
3.3, Effects o f apo E o teins on
The impact of apo E polymorphism on trait means in the 88 male and 113 female FCH relatives is summarized in Table 3 . Reported alcohol intake and smoking habits ap peared to be similar among the apo E phenotype groups. Of all 558 FCH relatives 6 individuals had an apo E2/2 phenotype without exhibiting a hyperlipidemia. With the whole group of affected ences related to gender were obfor plasma triglycerides, VLDL cholesser tcrol, VLDL triglycerides and HDL cholesterol. The significance of the overall difference for the traits between the 5 apo E phenotypes is depicted by the P value in a significant effect on chemical composition data of LDL particles (Table 4 ). The relative choles terol ester content was lower in subjects with phenotype E3/2 compared with those with E4/3 (Scheffe's test P < 0.05). The same was true when compared with subjects with E4/4 (Scheffe's test P C 0.01). The triglyceride content was higher in individuals with phenotype E3/2 compared with those with E3/3 and E4/3 (Scheffe's test P < 0.01). The phospholipid content was significantly lower in subjects with phenotype E4/4 compared with those with E3/3 (Scheffe's test P < 0.01) (Table 4 ). A sex difference was observed for the free choles terol content and for the C/P ratio. This C/P ratio in subjects with E3/2 compared with test P <{).05) and V7 * f subjects with E3/3 higher in subjects with E4/4 compared with with E3/2 (Table 4) .
Plasma concentrations of lipids, lipoproteins and apolipoproteins according to apo E phenotypes in 201 affected subjects of a FCH
Chemical composition of low density lipoproteins (in % dry mass) according to apo E phenotypes in 201 affected subjects with FCH
Effects o f apo E polymorphism on L D L sub fra c t ion distribution
The distribution of LD L subtractions in a LDL
•action profile were both described by the amount of cholesterol measured in each separated LDL subfraction (Fig. 1) , and by the continuous variable K , taking the relative contribution of LDL subfraction into account 5). D ata of 12 affected subjects were missing due to technical errors or lack of sufficient amount of a. As a consequence of the effect of apo E rphism on total plasma LDL cholesterol, individual LDL subfraction cholesterol concentrations were observed in patients with the apo E4/4 lowest with apo E3/2 phenotype (Fig. 1) . However, no effect of apo E polymorphism on the distribution of LDL sub fractions pattern was observed, despite the estabquantitativc (apo relatives a pre and FCH inance of heavy LDL ative K values in all apo E phenotype groups ( each apo E phenotype showed a predominance of tration in LDL1 (Fig. 1) .
Discussion
Although the genetic nature of FCH seems molipidemic subjects [8-10,12] and in liypercholesterolemic subjects [14], associated with the apo E phenotype. In the present study, we could demonstrate that the apo E polymorphism also contributes to the magnitude of lipid and lipo- protein concentrations among affected subjects of 40 well-defined FCH families. Like familial dysbetalipoproteinemia (FD) in which other factors next to the apo E2/2 pheno type contribute to the expression of the hyperlipidemia [26] , a similar coincidence of factors may appear in FCH. Clearly, the presumed overpro duction of VLDL particles as a primary cause of FCH, would be exaggerated by the differential effect of the apo e2 allele on VLDL remnants and of the apo s4 allele on LDL cholesterol. The effect of the apo s2 allele was confirmed by the observed accumulation of beta-VLDL in FCH subjects with extensive premature atherosclerosis related to a heterozygote apo E3/2 pattern [27] , which was independent of the LDL receptor status as reported by others [28] , In our FCH sample, indeed, higher VLDL cholesterol and triglycerides concentrations were observed in subjects with apo E3/2. The observed elevated LDL levels in sub jects with the possession of an apo E4 allele hypothetically results from the more efficient up take of chylomicrons and VLDL remnants by the liver increasing intracellular cholesterol, thereby reducing LDL receptor activity and thus elevating plasma LDL cholesterol levels [11] .
Distribution of LDL subfraction profiles, described by a continuous variable K according to apo E phenotypes in 189 affected subjects of a sample of Dutch FCH families
When apo E alleles effects are primarily related to FCH, the allele frequency would deviate from normal. In a comparative study between hypercholesterolemic patients and non-obese patients with combined hyperlipidemia (serum cholesterol > 7 .5 mmol/1 and serum triglyceride > 2.0 mmol/ 1) the apo s2 allele, together with smoking habits and fasting insulin concentrations explained 30% of the hypertriglyceridemia and the low HDLcholesterol levels [29] , Besides specific apo s2 re lated differences on plasma lipids, also the frequency of the apo s2 allele was higher in the combined hyperlipidemic group, which confirms that the apo s2 allele has a plasma triglyceride raising effect in primary hypercholesterolemic pa-We significant presence of apo s4 in our sample of FCH patient as compared with a representative Dutch control population [8] and the spouses in this study. The apo s2 frequency similar to the representation in the control population is in agreement with the confirming normal Consequently, this may imply that apo E2 iso form has only secondary modulating effects on the expression of FCH. The over-representation of apo E4 in our sample corresponds with results in strictly unrelated patients with primary com bined hyperlipidemia [31] , and also with the fre quency found in patients with coronary heart disease [32, 33] . Moreover, the normal apo E allele distribution in the spouses of our FCH families suggests that the over-representation of apo s4 is not simply explained by a high apo e4 allele frequency in spouses. Therefore, Hoiilston et al. suggested that the possession of the apo E4 allele is one of the predisposing genetic factors to the development of the combined hyperlipidemic phe notype of FCH [31] .
